Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



The influence of coffee mouthwash on oral mucositis degree on patients with chemotherapy

Brigitta Ayu Dwi Susanti, Amanda Marselin, Rudi Haryono.




Abstract
Cited by 0 Articles

Cancer patients undergoing chemotherapy treatment will experience various effects. One effect is a disruption in the oral cavity that is often known as oral mucositis. Oral mucositis is a collection of symptoms that can be observed by nurses. Side effects of oral mucositis can cause further infections in the oral cavity, decreased appetite, and will later affect the quality of life. The purpose of this study was to determine the degree of oral mucositis that occurs in patients undergoing chemotherapy at PKU Muhammadiyah Hospital in Yogyakarta before and after using coffee mouthwash. This research is a quasi study. Sampling was done with a purposive sampling technique with a sample size of 15. The results showed that The degree of oral mucositis mostly experienced by chemotherapy patients in this study was grade 1. There was a decrease in the degree of oral mucositis in patients after giving coffee mouthwash. The average degree of oral mucositis after the use of coffee mouthwash is 0.40. There was a significant change between before and after giving coffee mouthwash with a p-value

Key words: cancer patient, coffee mouthwash, oral mucositis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.